Larry Douglas Altstiel
CIK 1619444 · View on SEC EDGAR ↗
First SEC filing: July 7, 2022 · Latest: July 7, 2022
On this page
- Insider at Companies where this person is a reporting insider.
- Insider transactions Every share this person bought or sold, from Form 4 filings.
- Derivatives Options and other derivative holdings reported by this person.
- Initial holdings The stakes this person held when they first started reporting.
- Compensation Executive pay disclosed in company proxy statements.
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
No open-market trades on record; showing all filings.
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| Nov. 18, 2024 | PMN | A | 175,000 | — | — | 175,000 Direct | — | Acquired | (price as of 2026-08-21) |
| Oct. 26, 2023 | PMN | A | 12,500 | — | — | 12,500 Direct | — | Acquired | (price as of 2026-08-21) |
| Dec. 16, 2015 | VTVT | A | 140,000 | — | — | 140,000 Direct | — | Acquired | (price as of 2026-08-21) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II)
Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| Nov. 18, 2024 | PMN | Option (right to buy) | Common Shares (175,000) | $1.00 | Nov. 18, 2034 | 175,000 | Acquired |
| Oct. 26, 2023 | PMN | Option (right to buy) | Common Stock (12,500) | $1.87 | Oct. 26, 2033 | 12,500 | Acquired |
| Dec. 16, 2015 | VTVT | Employee stock option (right to buy) | Class A common stock (140,000) | $6.47 | Dec. 16, 2025 | 140,000 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Initial ownership (Form 3) 3 holdings
Securities held when first becoming an insider, per SEC Form 3.
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
PMN
Chief Medical Officer| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2025 | $425,000 | $57,000 | — | — | — | — | — | $544,196 |
| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2018 | $400,000 | — | — | — | — | — | $13,351 | $413,351 |
| 2017 | $400,000 | — | — | $536,447 | $34,000 | — | $22,381 | $992,828 |
| 2016 | $400,000 | — | — | — | $160,000 | — | $22,200 | $582,200 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.